VectorialDATA
Stocks/NOC

NOC — Northrop Grumman Corporation

IndustrialsNorth AmericaUnited StatesBlockchain certified

Price when we picked it (Sep 22, 2026)

$510.18

Target: $646.41 (+26.7%)

P/E Ratio

16.2

P/E Forward

16.8

Dividend

1.94%

Market Cap

$72.5B

EPS

$31.49

Consensus

Buy

What they do

Northrop Grumman (Falls Church, Virginia; ~95,000 employees; CEO Kathy Warden) designs and builds defense systems for the US and its allies in 4 segments.

  • Aeronautics: the B-21 Raider, the next-generation stealth bomber of which it is the sole maker, and drones like Global Hawk and Triton — $3.5 billion in second-quarter sales (+13%).
  • Mission Systems: radars, sensors, communications and cybersecurity — $3.3 billion (+3%), its most profitable segment (15.4%).
  • Space Systems: satellites, rocket motors and the Sentinel missile that will replace the Minuteman III — $2.8 billion (+4%).
  • Defense Systems: munitions, tactical missiles and the IBCS air defense system — $2.1 billion (+5%).

What's new in 2026: the B-21 agreed to produce 25% more per year and on September 9 opened a new plant in Layton, Utah; Sentinel added $7.6 billion in contracts and on September 14 the complete missile was assembled; the Space Force picked it to demonstrate orbital interceptors for the Golden Dome shield. Its goal is to double international sales to $10 billion a year by 2031.

Why we like it

Three reasons to add more.

  • IT EARNS MORE AND COSTS LESS: when we bought in March the company expected to earn $27.40–$27.90 per share in 2026; in July it raised that to $28.60–$29.10. Meanwhile the stock fell 26%: the P/E went from 23.5x to 16.2x.
  • WORK LOCKED IN: record backlog of $104.7 billion (~2.4 years of sales), $20 billion in new contracts in the second quarter alone, and Sentinel — March's big risk — is moving forward: first flight expected in 2027, sooner than expected.
  • IT PAYS YOU MORE TO WAIT: it raised the dividend 7% in May to $2.47 per quarter (1.94% at the purchase price, vs 1.35% in March). Buy consensus from 24 analysts with an average price target of $646.41 (+26.7%); in March the target was below the price.

Key Risk

The #1: delivering what it sells without losing money. Demand is plentiful, but margins are falling (10.6% vs 11.8% in the second quarter) and charges on fixed-price programs keep repeating: $71 million and then $91 million on the GEM 63XL rocket motor, $68 million on the SiAW missile, and in 2025 a $477 million loss on the B-21. Others:

  • peace: a deal with Iran strips the war premium from the sector — on September 22 it fell ~3% on the report that Iran offers to reopen Hormuz;
  • the January executive order limits buybacks and dividends for contractors that don't deliver on time (in the first half it bought back only $68 million);
  • more investment, flat free cash: it will spend ~$1.85 billion this year and did not raise its free cash flow outlook ($3.1–$3.5 billion);
  • it depends on the US budget: the $1.5 trillion proposal for 2027 is not approved.

This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.

Vectorial Data picked NOC on Mar 25, 2026 at $691.43.

Full Research

Northrop Grumman Corporation (NOC) — Complete Research

First purchase price (March 25, 2026): $691.43 | P/E: 23.46 | P/E Forward: 24.43 | Div Yield: 1.35% | Market Cap: $98B — see the September 2026 update at the end


What is Northrop Grumman?

Northrop Grumman is the second largest defense contractor in the US and the maker of the B-21 Raider, the most advanced next-generation stealth bomber in the world. It is also the main contractor for the Sentinel ICBM, the replacement for the Minuteman III. With a backlog of $95.7 billion, the company has income visibility for years.

Business Segments (FY2025)

SegmentRevenue% TotalKey Programs
Aeronautics Systems$13.0B29%B-21 Raider, Global Hawk, Triton, autonomous drones
Mission Systems$12.5B28%Radars, cybersecurity, C4ISR, advanced sensors
Space Systems$10.8B24%Satellites, GEM 63, ballistic missiles, Sentinel ICBM
Defense Systems$8.0B18%Munitions, IBCS, logistics, training

2025 Results (Full Year)

  • Revenue: $42.0B (+2% YoY)
  • Q4 Revenue: $11.71B (+9.6% YoY) — significant acceleration
  • EPS (Adjusted): $29.08
  • Free Cash Flow: $3.3B (+26% YoY — third consecutive year of 25%+ growth)
  • Backlog: $95.7B (record)
  • Book-to-Bill: 1.10x (receiving more orders than delivering)
  • Net Awards: $46B+ in 2025
  • International sales: +20% in 2025

2026 Guidance

  • Revenue: $43.5B - $44.0B (~4% growth)
  • EPS Adjusted: $27.40 - $27.90 (analyst consensus: $28.05)
  • Note: EPS down vs 2025 due to higher capital investments and B-21 production costs

The B-21 Raider — The Game Changer

The B-21 Raider is the largest bomber program in 30 years:

  • $4.5B expansion contract agreed in Feb 2026 to increase production capacity by +25%
  • Northrop investing an additional $2-3B of its own capital to accelerate
  • Current production: ~8 planes/year, rising to ~10/year
  • Minimum program: 100 planes (potential for more)
  • First operational plane: Will arrive at Ellsworth AFB in 2027
  • $5B+ invested in digital infrastructure and manufacturing
  • The program is not yet fully reflected in guidance — greater upside not captured

The ICBM Sentinel — The Known Risk

  • Nunn-McCurdy overrun: Estimated cost exceeds $141B, surpassing the legal threshold
  • Restructuring ongoing: Expected to conclude by the end of 2026
  • Test flight delayed: From 2026 to March 2028
  • Software issues and silo design complicate timeline
  • Operational capability: Not before early 2030s
  • Mitigant: Congress added $2.5B for risk reduction activities

Dividend and Shareholder Return

  • Annual dividend: $9.24/share (~1.35% yield)
  • Consecutive years of increase: 23
  • Last increase: +12% in May 2025
  • Buybacks 2025: ~$1.7B in repurchases
  • Current authorization: $4.2B in pending repurchases
  • Strategy: Return >100% of FCF to shareholders

Competitive Advantages (Moat)

  • B-21 Monopoly: Sole manufacturer of next-generation stealth bomber
  • #2 Pentagon Contractor: Only behind Lockheed Martin
  • $95.7B Backlog: ~2.3x annual sales visibility
  • Classified Programs: Multiple "black" programs impossible to replicate
  • Early Cycle Positioning: B-21 and Sentinel are in investment phase — strong revenue comes in future years
  • Leadership in Cybersecurity and C4ISR: Critical capabilities for modern warfare

The Defense Megatrend

  • NATO rises to 5% of GDP by 2035 — multiplies defense budgets in Europe
  • US defense up ~15% in FY2026 — NOC is a direct beneficiary
  • Active conflicts (Ukraine, Middle East) accelerate demand
  • International sales growing 20% — international book-to-bill >1 expected in 2026
  • New threats (hypersonics, cyberattacks, drones) require exactly what NOC manufactures

Catalysts

  • B-21 Raider expansion — $4.5B in additional capacity, production +25%, first operational plane in 2027
  • Record backlog $95.7B — visibility of ~2.3 years of revenue
  • Accelerating free cash flow — +26% in 2025, third year of 25%+ growth
  • International sales +20% — expanding market due to NATO 5%
  • US defense budget +15% — secular tailwind
  • Classified programs — upside not visible in public guidance

Main Risks

  • Sentinel ICBM in trouble: $141B+ cost overruns, restructuring, 4-year delays
  • Priced expensively: Forward price vs. profit of 24.4x is premium for ~4% sales growth
  • 2026 EPS down vs 2025: Guidance of $27.65 vs $29.08 achieved
  • Dependence on defense budget: Political changes or cuts could affect pipeline
  • B-21 execution risk: Massive program in ramp-up

Competitive Position

MetricNOCLMTRTXGD
Revenue$42B$75B$85B$46B
Backlog$95.7B$194B$217B$92B
Dividend Yield1.35%2.26%2.2%2.0%
P/E Forward24.4x20.5x~22x~20x
Defense focus90%100%65%65%

Analyst Consensus

MetricValue
RatingBuy (17 analysts)
Strong Buy5
Buy5
Hold7
Sell0
Average Price Target$675.29
High Price Target$815
Low Price Target$521
Upside to Target-2.2%

Conclusion

NOC at $691.43 is a bet on the future of US air and space defense. The B-21 Raider is the most important defense program of the next decade, and NOC is the sole manufacturer. With a record backlog of $95.7B, accelerating cash flow, and international sales growing 20%, the company has solid fundamentals. The main risk is the premium valuation (24.4x forward P/E) along with EPS dropping in 2026 due to capacity investments. However, these investments are what will drive future growth. For a diversified defense portfolio (complementing LMT), NOC offers unique exposure to stealth bombers, cybersecurity, and space systems.


Research date: Mar 25, 2026 | Next review: Sep 2026

This is not financial advice.


Update September 22, 2026 — Rebuy (Position #187)

Entry price: $510.18 | P/E on the last 12 months 16.2x | Forward P/E 16.7x (on expected 2027 earnings, $30.45 per share; ~17.6x on 2026) | Dividend 1.94% | Market value ~$72.5 billion. First purchase: #21 on March 25, 2026 at $691.43 (−26.2% since then). 52-week range: $479.02–$774.

What happened: why it fell 26%

  • We bought near the peak of the war euphoria. The stock hit its all-time high of $774 on March 3, 2026, when the war with Iran began. From early March to late April the ITA defense fund fell ~12% while the S&P 500 rose 3.5% (CNBC): the market had already priced in the war, sector earnings expectations were "skewed too high" (Bank of America) and people started talking about "peak defense".
  • First quarter (April 21): −7% in one day. Sales $9.9 billion (+4%) and earnings of $6.14 per share, above expectations. But the company only reaffirmed its annual outlook, used ~$1.82 billion of free cash in the quarter (seasonal), booked a $71 million unfavorable adjustment on the GEM 63XL rocket motor after a launch anomaly, and raised its 2026 investment by $200 million (to ~$1.85 billion) to build 25% more B-21 bombers per year. The stock went from $657 to $611 that day; Lockheed Martin fell more than 13% on its own report.
  • Second quarter (July 21): outlook up, stock down. Sales $10.9 billion (+5%); earnings $7.68 per share (−6%, because a year earlier there was a one-time $231 million gain from selling a business); record order backlog of $104.7 billion; new contracts of $20 billion (1.84 dollars in orders for every dollar billed). It raised its 2026 outlook: sales $43.75–$44.25 billion and adjusted earnings of $28.60–$29.10 per share (+$1.20). But segment margin fell to 10.6% from 11.8%, part of the positive surprise came from a 6.3% tax rate (vs 17.7%), there were charges of $91 million (GEM 63XL) and $68 million (SiAW missile), and it did not raise its free cash flow outlook ($3.1–$3.5 billion). It closed −2.2% at $512.29.
  • Peace takes away the war premium (August–September). Signs of a deal with Iran pushed the ITA fund from ~$253 (week of August 10) to ~$214. On September 22, a Reuters report that Iran offers to reopen the Strait of Hormuz within 7 days knocked Lockheed and RTX down ~3%; NOC opened at $527.15 and we bought at $510.18.
  • The January 7, 2026 executive order ("Prioritizing the Warfighter in Defense Contracting") bars major contractors from buying back stock or paying dividends at the expense of producing more and on time. In the first half NOC bought back just $68 million of stock (and paid $684 million in dividends).

Why we are buying again

  • The company earns more; the stock costs less. When we bought, the 2026 earnings outlook was $27.40–$27.90 per share; today it is $28.60–$29.10. The P/E fell from 23.5x to 16.2x and the dividend went from 1.35% to 1.94%.
  • The dividend kept rising despite the order: +7% to $2.47 per quarter ($9.88 a year), announced May 19, 2026; it uses ~30% of earnings.
  • Record backlog: $104.7 billion (+9% since December, +17% in a year), ~2.4 years of sales.
  • Sentinel, once the big risk, is moving forward: $7.6 billion in contracts in the second quarter; on September 14 they assembled the complete missile for the first time and the first integrated flight is expected in 2027 (in March the schedule pointed to March 2028).
  • B-21: on September 9 it opened the East Gate 3 plant in Layton, Utah (845,000 square feet); the Air Force finishes its analysis to speed up production even more before year-end.
  • Other engines: the Space Force picked it to demonstrate orbital interceptors for the Golden Dome shield (on-orbit capability planned for 2027); 10 new multi-year tactical missile agreements worth up to $10 billion over 7 years; a goal of doubling international sales to $10 billion a year by 2031; the president proposed a $1.5 trillion military budget for 2027 (vs $901 billion approved for 2026), pending in Congress.
  • Analysts: Buy consensus (24 analysts: 10 strong buy, 4 buy, 10 hold, 0 sell), average price target $646.41 (+26.7%), range $538–$815. In March the average target ($675.29) was below the price; today even the lowest target is above it.

The honest part: the case is not perfect

Northrop's problem is not demand but execution: margins are falling, charges on fixed-price programs keep repeating (GEM 63XL, SiAW; in 2025, a $477 million loss on the B-21), investment is rising (~4.5% of sales in 2027–2028) and free cash flow is not growing this year. Peace with Iran can keep deflating the sector and the executive order limits buybacks. The stock is below its 50-day ($542.79) and 200-day ($600.94) averages. Next report: October 20, 2026. We are buying again on price and on rising earnings, not on momentum.

Update: Sep 22, 2026 | Next review: Mar 2027

More picks in Industrials

See all Industrials picks →

More picks from United States

See all picks from United States →
Researched: Mar 25, 2026Updated: Sep 22, 2026Next review: Mar 22, 2027

This is not financial advice. Consult a certified financial advisor.

The author may hold positions in the securities discussed.

Past performance does not guarantee future results.